Related Experiment Video
Updated: Jun 3, 2026

11:00
Targeted Training of Ultrasonic Vocalizations in Aged and Parkinsonian Rats
Published on: August 8, 2011
Long-term hyperglycaemia induces qualitative and quantitative changes in rat ultrasonic vocalizations
Justine Renaud1, Jimmy Beaulieu1, Jacopo Marongiu2
1Cellular Neurobiology, Department of Medical Biology, Université du Québec, Trois-Rivières, Québec, Canada.
Scientific Reports
|June 1, 2026
Summary
Long-term diabetic hyperglycemia in male rats alters ultrasonic vocalizations (USVs), indicating changes in emotional states. This suggests USVs can be a valuable tool for studying diabetes mellitus (DM) effects.
Area of Science:
- Neuroscience
- Behavioral Biology
- Endocrinology
Background:
- Diabetes mellitus (DM) is a global epidemic linked to mood disorders and behavioral changes.
- Emotional state alterations may mediate the relationship between DM and behavioral traits.
Purpose of the Study:
- To investigate the impact of long-term diabetic hyperglycemia on ultrasonic vocalizations (USVs) in male rats.
- To explore USVs as a potential behavioral marker for emotional state changes in diabetes.
Main Methods:
- Male rats with long-term hyperglycemia (HG) or controls (CTRL) were exposed to conspecifics.
- Emission of 50-kHz (appetitive) and 22-kHz (aversive) USVs was analyzed for number and acoustic parameters.
- USVs were categorized into flat and frequency-modulated types.
Main Results:
- HG rat dyads emitted significantly more 50-kHz USVs than CTRL dyads.
- Distinct acoustic differences were observed in 50-kHz USVs between HG and CTRL rats.
- A subset of HG rats (30%) emitted 22-kHz USVs, unlike CTRL rats.
Conclusions:
- Long-term diabetic hyperglycemia induces significant quantitative and qualitative changes in rat ultrasonic vocalizations.
- USV analysis offers a promising method for assessing hyperglycemia's effects in diabetes models.
Related Concept Videos
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

